Skip to Main Content

Author Details

Frank K Braun
University Hospital Regensburg
2007
31
17
PMIDPaper TitleJournal TitlePublished Year
37415222Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models.J Transl Med2023
37508520Scaffold-Based (Matrigelâ¿¢) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype.Cells2023
37158962TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma.Acta Neuropathol Commun2023
34802040Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies.Lab Invest2022
36550163Publisher Correction: Epigenetic alterations of repeated relapses in patient-matched childhood ependymomas.Nat Commun2022
36335125Epigenetic Alterations of Repeated Relapses in Patient-matched Childhood Ependymomas.Nat Commun2022
35182954Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma.Transl Oncol2022
33358190Corrigendum to "Impact of SCID mouse gender on tumorigenicity, xenograft growth and drug-response in a large panel of orthotopic PDX models of pediatric brain tumors" [Cancer Lett. 493 (2020) 197-206].Cancer Lett2021
34719887Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion.Adv Sci (Weinh)2021
32891713Impact of SCID mouse gender on tumorigenicity, xenograft growth and drug-response in a large panel of orthotopic PDX models of pediatric brain tumors.Cancer Lett2020
31693904Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.Cell Rep2019
28690315Targeting nucleolin for better survival in diffuse large B-cell lymphoma.Leukemia2018
30355798Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma.Sci Transl Med2018
29463553Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models.Clin Cancer Res2018
29152094Xenotransplantation of pediatric low grade gliomas confirms the enrichment of <i>BRAF</i> V600E mutation and preservation of <i>CDKN2A</i> deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma.Oncotarget2017
26956263Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma.J Neurooncol2016
25738497Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis.PLoS One2015
26565401HMGB1 Promotes Mitochondrial Dysfunction-Triggered Striatal Neurodegeneration via Autophagy and Apoptosis Activation.PLoS One2015
26048374Targeting Wnt pathway in mantle cell lymphoma-initiating cells.J Hematol Oncol2015
24811343FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.Leukemia2014
25304249CD74 interferes with the expression of fas receptor on the surface of lymphoma cells.J Exp Clin Cancer Res2014
2504045090Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.Br J Haematol2014
25079679Expression of acid-sensing ion channels in nucleus pulposus cells of the human intervertebral disk is regulated by non-steroid anti-inflammatory drugs.Acta Biochim Biophys Sin (Shanghai)2014
23599269Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex.Blood2013
22011910Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand.J Invest Dermatol2012
22551975Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling.J Invest Dermatol2012
21625233Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome.Leukemia2011
19890350Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP.J Invest Dermatol2010
20812013[cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells].Pathologe2010
20237495Enhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac/hyaluronic acid correlates with downregulation of c-FLIP.J Invest Dermatol2010
17495957Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells.J Invest Dermatol2007
  • 1 - 31 of 31

Recommended Authors

Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Cellworks Group Inc.
Career Start Year 2011
Number of shared co-authors 0
Seoul National University, College of Medicine
Career Start Year 2010
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 4
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 0
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 1
City of Hope National Medical Center
Career Start Year 2005
Number of shared co-authors 0
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 2
Institute for Refractory Cancer Research, Samsung Medical Center
Career Start Year 2004
Number of shared co-authors 0
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Career Start Year 2003
Number of shared co-authors 0
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 0
Medical University of Graz
Career Start Year 2000
Number of shared co-authors 0
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
College of Medicine, The Catholic University of Korea
Career Start Year 1996
Number of shared co-authors 0
Oncode Institute
Career Start Year 1993
Number of shared co-authors 0
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 2
Oncology Research Unit, Inc.
Career Start Year 1991
Number of shared co-authors 0
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 4
Winship Cancer Institute, Emory University
Career Start Year 1988
Number of shared co-authors 2
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 5
Johns Hopkins School of Medicine
Career Start Year 1986
Number of shared co-authors 1
University of California San Francisco
Career Start Year 1985
Number of shared co-authors 0
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 1984
Number of shared co-authors 4
Universite Cote d'Azur, INSERM U5
Career Start Year 1982
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1979
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1978
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1977
Number of shared co-authors 1

Collaborators

Xiangya Hospital of Central South University
Co-authored papers 14
Northwestern University
Co-authored papers 13
Texas Children's Cancer Center, Baylor College of Medicine
Co-authored papers 13
Texas Children's Cancer Center
Co-authored papers 13
Texas Children's Cancer Center, Baylor College of Medicine
Co-authored papers 12
Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine
Co-authored papers 12
Texas Children's Cancer Center, Baylor College of Medicine
Co-authored papers 8
Baylor College of Medicine
Co-authored papers 5
National Cancer Institute
Co-authored papers 2
Texas Children's Hospital
Co-authored papers 2
Broad Institute of MIT and Harvard
Co-authored papers 1
Collegeville
Co-authored papers 1
The University of Texas Health Science Center at San Antonio
Co-authored papers 1
Sun Yat-sen University Cancer Center
Co-authored papers 1
Cancer Center, Texas Tech University Health Sciences Center School of Medicine
Co-authored papers 1
Co-authored papers 1
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers 1
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 1
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 1
Baylor College of Medicine
Co-authored papers 1
Leibniz Institute for Immunotherapy (LIT)
Co-authored papers 1
Greehey Children's Cancer Research Institute
Co-authored papers 1
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 1
Co-authored papers 1
Houston Methodist Research Institute
Co-authored papers 1
University of Pennsylvania Perelman School of Medicine
Co-authored papers 1
Co-authored papers 1
Baylor College of Medicine
Co-authored papers 1
Children's Hospital of Philadelphia
Co-authored papers 1
Greehey Children's Cancer Research Institute
Co-authored papers 1